Brewer, George J <br/><br/>
Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease.  [electronic resource] 

 -  Archives of neurology  Apr 2006 
 - 521-7 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0003-9942 
<br/><br/><label>Standard No.: </label>10.1001/archneur.63.4.521  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Anemia--chemically induced<br/>Chelating Agents--administration & dosage<br/>Copper--antagonists & inhibitors<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Female<br/>Hepatolenticular Degeneration--drug therapy<br/>Humans<br/>Length of Stay<br/>Male<br/>Middle Aged<br/>Molybdenum--administration & dosage<br/>Serum Albumin--drug effects<br/>Speech--drug effects<br/>Speech Disorders--drug therapy<br/>Treatment Outcome<br/>Trientine--administration & dosage<br/>Zinc--therapeutic use